The health headlines move fast and most coverage gets the science wrong. Every day, Dr. Ravi Kumar, MD, a board-certified neurosurgeon, cuts through the noise: what a new study or story actually says, what it doesn’t, and what it means for you. Researched, sourced, and reviewed before it’s published.
A reanalysis of 431 participants in the DIETFITS trial found that people with a genetic tendency toward high LDL saw the biggest cholesterol increases on a low-carb diet, and the effect tracked with how much saturated fat they ate.
In more than 200,000 US adults followed for four decades, what people ate predicted heart disease, type 2 diabetes and death, while whether the food came from a factory did not.
NIH researchers compared four photo-based apps against meals weighed to the tenth of a gram, and every app missed roughly a third of the calories, with high-fat ketogenic meals faring worst.
Researchers screened more than 5,000 blood proteins in a cohort followed for nearly 20 years and built a 19-protein panel that estimates the timing of ALS onset in people who carry a high-risk gene.
The Senate HELP Committee voted 12-10 to advance the Childhood Diabetes Reduction Act, which would put warning labels on ultra-processed foods and ban junk food ads aimed at children.
A new JAMA Network Open study of 133,606 matched adults found a 21% lower three-year fracture risk on GLP-1 drugs overall, but a higher risk in the growing group of users who do not have type 2 diabetes.
The FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 to recommend adding BPC-157, KPV, TB-500 and MOTS-c to the Section 503A Bulks List, rejecting the agency's own reviewers, who had proposed that none of them be included.
Federal investigators have linked 1,947 Cyclospora illnesses and at least 98 hospitalizations in nine states to shredded iceberg lettuce recalled by Taylor Farms de Mexico, and the case count is still climbing.
A target trial emulation in The BMJ found 37% more hair loss diagnoses among adults with type 2 diabetes who started a GLP-1 drug than among those who started an SGLT-2 inhibitor, and the FDA is now evaluating the finding as a formal safety signal.
The CDC has confirmed 2,318 measles cases so far in 2026, already more than all of last year and the highest total since 1991, as kindergarten vaccination coverage slips to 92.5%.